Eli Lilly's John Lechleiter was one of six pharma CEOs to make the <em>New York Times</em> 2013 executive-pay ranking, but he wasn't at the top of the list of highly paid drug industry execs. That position went to Abbott's Miles White, who saw his pay rise 8% to $20.5 million, placing him in the 13th spot overall on the <em>NYT</em> list.
written on 21.04.2014